Photo of Margaret A. Satchell

Margaret A. Satchell

  • ASSISTANT PROFESSOR Pediatrics, Pediatric Critical Care Medicine
Print ProfilePrint Profile

Clinical Focus

Education

  • MD, Dartmouth Medical School

  • Residency, Pediatrics
    Children's Hospital of Pittsburgh

  • Fellowship, Pediatric Crit. Care
    Children's Hospital of Pittsburgh

  • Fellowship, Research
    University of Pittsburgh

Biography

    Dr. Satchell earned her M.D. from the Dartmouth Medical School and went on to do her residency in General Pediatrics at the Children's Hospital of Pittsburgh. She completed a fellowship in Pediatric Critical Care also at the Children's Hospital of Pittsburgh and an NICHD Research fellowship at the Safar Center for Resuscitation Research at the University of Pittsburgh. Dr. Satchell's many honors include Alpha Omega Alpha, member since 1994 and the Annual Scientific Award from the Society of Critical Care Medicine in 2000 and again in 2001.

Research

Dr. Satchell's research has focused on the cellular mechanisms involved in neuronal death after traumatic brain injury.

Publications

Satchell MA, Zhang X, Jenkins LW, Kochanek PM, Marion DW, Nathaniel PD, Graham SH, Clark RS B. Increase in phospho-BAD via protein kinase B (PKB) after human head injury. J Neurotrauma 2001; 18(10).

Zhang X, Satchell MA, Clark RS B, Nathaniel PD, Kochanek PM, Graham SH. In: Brain Injury: Molecular and Cellular Biology of Critical Care Medicine. Clark, RSB, Kochanek, PM, eds. Kluwer Academic Publishers, Boston 2001;.

Clark RS B, Satchell MA. Albumin in brain injury: Not just for pressure anymore. Pediatric Critical Care Medicine 2001; 2:3(Suppl): S38-39.

Satchell MA, Kochanek PM, Marion DW, Watkins SC, Alber SC, Clark RS B. Nitrosative stress after severe traumatic brain injury in humans. Critical Care Med 2002; 29(Suppl).

Fink EL, Satchell MA, Kochanek PM, Adelson PD, Janesko KL, Thomas NJ, Clark RS B. Hepatocyte growth factor (HGF) in CSF of infants and children after severe traumatic brain injury. Critical Care Med 2002; 29(Suppl).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Satchell did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Kravis Children's Hospital
1184 Fifth Avenue, 6th Floor, Rm 325
New York, NY 10029

Tel: 212-241-7866